Skip to main content

guidelines to provide for the prevention and regulation of dark patterns, namely

CENTRAL CONSUMER PROTECTION AUTHORITY NOTIFICATION New Delhi, the 30th November, 2023 F. No. CCPA-1/1/2023-CCPA -(Reg).—In exercise of the powers conferred by section 18 of the Consumer Protection Act, 2019 (35 of 2019), the Central Consumer Protection Authority hereby issues the following guidelines to provide for the prevention and regulation of dark patterns, namely:- 1. Short title and commencement. —(1) These guidelines may be called the Guidelines for Prevention and Regulation of Dark Patterns, 2023 (2) It shall come into force on the date of its publication in the Official Gazette. 2. Definitions.- (1) In these guidelines, unless the context otherwise requires,- (a) “Act”- means the Consumer Protection Act, 2019 (35 of 2019); (b) “Advertiser” shall have the same meaning as defined under the Guidelines for Prevention of Misleading Advertisements and Endorsements for Misleading Advertisements, 2022; (c) “Central Consumer Protection Authority” shall mean the authority established under section 10 of the Consumer Protection Act 2019 (35 of 2019); (d) “commercial gains” mean monetary gain or financial advantage of any kind; (e) “dark patterns” shall mean any practices or deceptive design pattern using user interface or user experience interactions on any platform that is designed to mislead or trick users to do something they originally did not intend or want to do, by subverting or impairing the consumer autonomy, decision making or choice, amounting to misleading advertisement or unfair trade practice or violation of consumer rights; https://consumeraffairs.nic.in/sites/default/files/file-uploads/latestnews/The%20Guidelines%20for%20Prevention%20and%20Regulation%20of%20Dark%20Patterns%2C%202023.pdf

Popular posts from this blog

Elizabeth Holmes Discusses Theranos at WSJDLive 2015

Elizabeth Holmes Discusses Theranos at WSJDLive 2015 Elizabeth Holmes Discusses Theranos at WSJDLive 2015 At the WSJDLive 2015 conference, Theranos founder and CEO Elizabeth Holmes discusses her company's proprietary technologies, the FDA's inspection of its facilities, and the assertion that her company was too quick to market its products.